glp-1 eating disorder Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Disorder: A Narrative Review GLP-1 drugs are effective for

That distribution overlaps almost exactly with the circuits implicated in neurodegeneration, addiction, and mood disorders, which is why neuroscientists began paying attention

They improve insulin sensitivity

Sepesi B, Parra Cuentes E, Canales J, Behrens C, Correa A, Antonoff M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S , Wistuba I

GLP-1 Targeted Peptide Weight Loss Drugs Market, by Therapy Line, 20242034 Table 7: U.S

Cagrilintide mimics these physiological actions by: Activating amylin receptors involved in appetite regulation Increasing feelings of fullness after meals Reducing overall food intake Delaying gastric emptying Supporting healthier glucose metabolism Promoting improved lipid metabolism Why Researchers Are Interested in Cagrilintide Obesity remains one of the world's fastest-growing health concerns